… breast cancer hormonal therapy is "the first-line treatment even in case of visceral metastases
if hormone therapy … Patients with HR+ metastatic cancer are eligible for hormone therapy if …

… ) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects
of various systemic adjuvant therapies on breast cancer recurrence and survival. Here, we …

… This article will review each of these hormonal therapies (ovarian suppression, tamoxifen, …
the treatment of hormone-sensitive early breast cancer. Ovarian ablation as adjuvant therapy …

… B ) Invasive breast cancer incidence by hormone therapy group. Hazard ratios (HRs) are …
To understand how concepts about hormone therapy and breast cancer have evolved over time…

… Hormone therapy is an effective and non-toxic therapy for oestrogen and progesterone
receptor-positive breast cancer and prostate cancer. … breast cancer and men with prostate cancer, …

… breast cancer associated with the use of hormone therapy for menopause varies by histological
type. We aimed to describe such associations for eight histological types of breast cancer…

… Hormone therapy is an effective and non-toxic therapy for … receptor-positive breast cancer
and for prostate cancer. Serum … women with breast cancer and men with prostate cancer, …

… receptorcontaining breast cancer for which systemic therapy is … hormonal treatment of breast
cancer will relate the current state of clinical practice to recent advances in hormonal therapy…

… In premenopausal women with breast cancer and men with prostate cancer, hormonal …
Indications for hormonal therapy Hormone therapy in breast cancer may be used in four main …

… on Hormonal Factors in Breast Cancer established an association between menopausal
hormone therapy and breast cancer … They found breast cancer risk to increase by 2.3% for each …